Related Experiment Video

Updated: May 23, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

Synergistic Effect of Hyperglycemia and p27(kip1) Suppression on Adult Mouse Islet Beta Cell Replication

Szu-Tah Chen1, Shin-Huei Fu, Samuel Hsu

  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang-Gung Medical Center and Chang-Gung University, Taoyuan 333, Taiwan.

International Journal of Endocrinology
|April 17, 2012
PubMed

Insights

Hyperglycemia and p27(kip1) suppression work together to boost islet beta cell regeneration. This finding offers new insights into improving beta cell function for diabetes treatment.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Regenerative Medicine

Background:

  • Islet beta cell regeneration is crucial for managing diabetes.
  • The roles of hyperglycemia and p27(kip1) in beta cell replication require further elucidation.

Purpose of the Study:

  • To investigate the synergistic effects of hyperglycemia and p27(kip1) suppression on islet beta cell regeneration.
  • To assess the therapeutic potential of targeting p27(kip1) for enhancing beta cell function.

Main Methods:

  • Utilized a syngeneic mouse model for islet transplantation.
  • Employed shRNA lentiviral particles for p27(kip1) gene silencing in islets.
  • Quantified p27(kip1) protein levels and assessed beta cell proliferation (Ki67 staining) post-transplantation.

Main Results:

  • p27(kip1) gene silencing significantly reduced p27(kip1) protein content in islets.
  • Targeting islets showed increased beta cell proliferation (Ki67+ nuclei) compared to controls.
  • Mice receiving targeted islets experienced shorter hyperglycemia duration and higher cumulative diabetes cure rates.

Conclusions:

  • Hyperglycemia and sustained p27(kip1) suppression synergistically promote islet beta cell replication in adult mice.
  • p27(kip1) silencing holds promise for enhancing beta cell graft function and diabetes treatment.

More Related Videos

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination12:33

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination

Published on: June 25, 2014

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.